RGD Reference Report - Identification of pancreatic cancer invasion-related proteins by proteomic analysis. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Identification of pancreatic cancer invasion-related proteins by proteomic analysis.

Authors: Walsh, N  O'Donovan, N  Kennedy, S  Henry, M  Meleady, P  Clynes, M  Dowling, P 
Citation: Walsh N, etal., Proteome Sci. 2009 Feb 14;7:3.
RGD ID: 2325688
Pubmed: PMID:19216797   (View Abstract at PubMed)
PMCID: PMC2646716   (View Article at PubMed Central)
DOI: DOI:10.1186/1477-5956-7-3   (Journal Full-text)

BACKGROUND : Markers of pancreatic cancer invasion were investigated in two clonal populations of the cell line, MiaPaCa-2, Clone #3 (high invasion) and Clone #8 (low invasion) using proteomic profiling of an in vitro model of pancreatic cancer. MATERIALS AND METHODS : Using 2D-DIGE followed by MALDI-TOF MS, two clonal sub-populations of the pancreatic cancer cell line, MiaPaCa-2 with high and low invasive capacities were incubated on matrigel 24 hours prior to analysis to stimulate cell-ECM contact and mimic in vivo interaction with the basement membrane. RESULTS : Sixty proteins were identified as being differentially expressed (> 1.2 fold change and p < or = 0.05) between Clone #3 and Clone #8. Proteins found to have higher abundance levels in the highly invasive Clone #3 compared to the low invasive Clone #8 include members of the chaperone activity proteins and cytoskeleton constituents whereas metabolism-associated and catalytic proteins had lower abundance levels. Differential protein expression levels of ALDH1A1, VIM, STIP1 and KRT18 and GAPDH were confirmed by immunoblot. Using RNAi technology, STIP1 knockdown significantly reduced invasion and proliferation of the highly invasive Clone #3. Knockdown of another target, VIM by siRNA in Clone #3 cells also resulted in decreased invasion abilities of Clone #3. Elevated expression of STIP1 was observed in pancreatic tumour tissue compared to normal pancreas, whereas ALDH1A1 stained at lower levels in pancreatic tumours, as detected by immunohistochemistry. CONCLUSION : Identification of targets which play a role in the highly invasive phenotype of pancreatic cancer may help to understand the biological behaviour, the rapid progression of this cancer and may be of importance in the development of new therapeutic strategies for pancreatic cancer.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
pancreatic cancer  IEP 2325688protein:decreased expression:pancreasRGD 
pancreatic cancer  ISOALDH1A1 (Homo sapiens)2325688; 2325688protein:decreased expression:pancreasRGD 

Objects Annotated

Genes (Rattus norvegicus)
Aldh1a1  (aldehyde dehydrogenase 1 family, member A1)

Genes (Mus musculus)
Aldh1a1  (aldehyde dehydrogenase family 1, subfamily A1)

Genes (Homo sapiens)
ALDH1A1  (aldehyde dehydrogenase 1 family member A1)


Additional Information